ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 8 Issue 1, Spring 1994

April 13, 1994

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

NIH Extramural Office Lists Initiatives For Reinvention

January 13, 1995